Ningbo Sanxing Medical Electric Co Ltd
SSE:601567
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17.62
36.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Ningbo Sanxing Medical Electric Co Ltd
Ningbo Sanxing Medical Electric Co Ltd
Cash & Cash Equivalents
Ningbo Sanxing Medical Electric Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ningbo Sanxing Medical Electric Co Ltd
SSE:601567
|
Cash & Cash Equivalents
¥2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
|
Tbea Co Ltd
SSE:600089
|
Cash & Cash Equivalents
¥20.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Gongniu Group Co Ltd
SSE:603195
|
Cash & Cash Equivalents
¥4.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
EVE Energy Co Ltd
SZSE:300014
|
Cash & Cash Equivalents
¥8.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
52%
|
|
|
Sungrow Power Supply Co Ltd
SZSE:300274
|
Cash & Cash Equivalents
¥15B
|
CAGR 3-Years
30%
|
CAGR 5-Years
56%
|
CAGR 10-Years
33%
|
|
|
Contemporary Amperex Technology Co Ltd
SZSE:300750
|
Cash & Cash Equivalents
¥232.3B
|
CAGR 3-Years
51%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Ningbo Sanxing Medical Electric Co Ltd
Glance View
Ningbo Sanxing Medical Electric Co. Ltd. is a burgeoning player in the healthcare technology sector, distinguished by its innovative medical equipment and a commitment to improving patient care through advanced electronic solutions. Founded in the dynamic industrial hub of Ningbo, China, the company has successfully carved a niche in the development and manufacturing of high-quality medical devices, including surgical instruments, diagnostic apparatus, and therapeutic equipment. With an emphasis on research and development, Sanxing is not just keeping pace with the rapidly evolving medical landscape; it is actively shaping it. By leveraging cutting-edge technology and adhering to stringent international quality standards, the company has established a strong reputation both domestically and globally, engendering trust and loyalty among its growing customer base. For investors, Ningbo Sanxing represents a unique opportunity in a sector poised for growth, driven by increasing global healthcare demands and advancements in medical technology. The company’s strategic partnerships with hospitals, research institutions, and other stakeholders illustrate a robust business model built on collaboration and innovation. Furthermore, with a focus on enhancing operational efficiency and expanding its product line, Sanxing is well-positioned to capitalize on emerging market trends, including telemedicine and personalized healthcare solutions. As the world leans more towards digital health solutions and responsive healthcare systems, investing in Ningbo Sanxing could yield promising returns, aligning with long-term trends in both healthcare and technology sectors.
See Also
What is Ningbo Sanxing Medical Electric Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.1B
CNY
Based on the financial report for Jun 30, 2024, Ningbo Sanxing Medical Electric Co Ltd's Cash & Cash Equivalents amounts to 2.1B CNY.
What is Ningbo Sanxing Medical Electric Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
13%
Over the last year, the Cash & Cash Equivalents growth was 30%. The average annual Cash & Cash Equivalents growth rates for Ningbo Sanxing Medical Electric Co Ltd have been 3% over the past three years , 8% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
